Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022

 

Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Assist Prof Dr. Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Rambam Health Care Campus | Israel

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Shadi Hamoud's academic journey began with the completion of his MD (cum laude) from the Faculty of Medicine at the Hebrew University, Jerusalem, in 1995. His commitment to medical excellence was evident from the beginning, as he specialized in Internal Medicine during his residency at Rambam Medical Center from 1996 to 2002. His passion for teaching also emerged early, as he served as a tutor and lecturer for medical students and advanced nursing courses at Rambam Health Care Campus.

Professional Endeavors 🏥

Dr. Hamoud has held several key roles throughout his career. Since 2010, he has been the Director of the Clinical Research Unit at the Internal Medicine E Department, Rambam Medical Center. He also serves as the Deputy Director of the same department. His expertise is sought by major pharmaceutical companies such as Bayer and Pfizer, where he has been a medical consultant since 2016 and 2017, respectively. Additionally, Dr. Hamoud plays a vital role on various medical committees, including the committee for blood product transfusions at Rambam and the specialty committee within the hospital.

Contributions and Research Focus 🔬

Dr. Hamoud's research interests are broad, focusing on critical issues in cardiovascular medicine, diabetes, and novel COVID-19 treatments. He has investigated lipoprotein oxidation and atherosclerosis, as well as the enzyme heparanase and its impact on kidney injuries, fatty liver disease, and other conditions. His involvement in international clinical trials and research on lipid-modifying drugs and new oral anticoagulants highlights his commitment to advancing medical science.

Accolades and Recognition 🏅

Dr. Hamoud has received numerous awards throughout his career, recognizing his dedication to both medicine and education. Between 2003 and 2016, he was named an Excellent Lecturer by the Internal Medicine E Department at Rambam Health Care Campus. In 2008, he was also honored with an Excellence in Medicine award, further cementing his reputation as a distinguished medical professional.

Impact and Influence 🌍

Dr. Hamoud’s influence extends beyond academia and clinical practice. He has been actively involved in public health education, delivering lectures at local schools in his hometown of Majd Al-Kurum. His role as an examiner in Israel’s internal medicine specialization exams underscores his commitment to shaping the next generation of medical professionals. He has also contributed to the medical field through his membership in professional societies, including the European Society of Hypertension and the Israeli Society of Hypertension.

Legacy and Future Contributions 🌱

Dr. Hamoud's work in medical research, clinical practice, and education has left a lasting impact on the healthcare field in Israel and beyond. His ongoing roles in clinical research, his contributions to new therapies for chronic diseases, and his mentorship of future doctors ensure that his influence will continue to grow. As a leader in both medicine and research, his legacy is one of commitment to improving health outcomes and advancing scientific knowledge for the benefit of future generations

 

Publications

  • 📄"Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury" 🐭
    Authors: Heba Abd Alkhaleq, Shadi Hamoud, Israel Hacker, Tony Karram, Ahmad Fokra, Aviva Kabala, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2024
  • 📄"Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure" 🐀
    Authors: Ravit Cohen-Segev, Omri Nativ, Safa Kinaneh, Doron Aronson, Aviva Kabala, Shadi Hamoud, Tony Karram, Zaid Abassi
    Journal: International Journal of Molecular Sciences
    Year: 2023
  • 📄"Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice" 🧬
    Authors: Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud
    Journal: Journal of Clinical Medicine
    Year: 2022

 

Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Ylenia Della Rocca | Medicine and Dentistry | Best Researcher Award

University of Chieti | Italy

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Ylenia Della Rocca’s academic journey began with exceptional achievements in biotechnology. In 2018, she earned her degree in Biotechnology with a perfect score of 110/110 cum laude from the University of L'Aquila. Her thesis, centered on "Hairy Cell Leukemia," set the stage for her future in oncohematological genetics. She continued to excel with a Master’s degree in Medical Biotechnology, again graduating with academic praise. Her research on the HLA-G 3' UTR region in kidney transplantation at the National Research Center solidified her expertise in medical biotechnology.

🏥 Professional Endeavors

Currently, Dr. Della Rocca serves as a Researcher Technologist and Subject Expert in Histology and Embryology at the University of Chieti. Her impressive academic trajectory culminated in a Ph.D. in "Innovative Technologies in Clinical Medicine & Dentistry" in 2024. As part of her doctoral research, she developed a new iPS cell line during her tenure at the University of Barcelona and Josep Carreras Leukaemia Research Institute. Beyond her role as a researcher, Dr. Della Rocca has been a prominent speaker at numerous international conferences, where her work has garnered significant recognition.

🔬 Contributions and Research Focus

Dr. Della Rocca’s research is at the forefront of biotechnology and regenerative medicine. Her completed and ongoing projects include the development of three-dimensional disease models, studies on tissue differentiation, and the establishment of new iPS cell lines. She has also been pivotal in creating innovative models for carcinogenesis research. Her current patent under review—"Pluripotent Stem Cells Induced by Autologous Gingival Stem Cells and Extracellular Vesicles: A Novel Approach for Cardiac Regeneration"—underscores her groundbreaking contributions to stem cell therapies and regenerative medicine.

🏆 Accolades and Recognition

Dr. Della Rocca’s research career has been marked by numerous accolades, including two prestigious awards for her scientific achievements. She has been a Guest Editor for special issues in renowned journals like the International Journal of Molecular Sciences and has served as a Review Editor for Frontiers in Genetics and Frontiers in Cell and Developmental Biology. Her citation index of 10 reflects the growing impact of her research in the scientific community.

🌍 Impact and Influence

Dr. Della Rocca’s work transcends academic research, as evidenced by her collaborations with top universities and research institutes worldwide, including the University of Barcelona, IRCCS Sicily, and the University of Montreal. She is an active member of the Italian Society of Anatomy and Histology and the Sigma Xi Scientific Research Honor Society. Dr. Della Rocca’s commitment to healthcare is further exemplified by her founding of Associazione Sorrisi in Ospedale (A.S.I.O.), a third-sector organization aimed at improving patient care in hospitals.

🔮 Legacy and Future Contributions

As a leader in the fields of stem cells, bioengineering, and regenerative medicine, Dr. Ylenia Della Rocca continues to push the boundaries of scientific knowledge. Her contributions to cell-free therapies and the development of three-dimensional models hold immense promise for future medical applications. With her ongoing work in stem cell regeneration and epigenetic research, Dr. Della Rocca is poised to shape the next frontier of clinical and research tools, leaving a lasting legacy in biotechnology.

 

Publications

📄 Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
Authors: Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani, Jacopo Pizzicannella
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Biological Effects of PMMA and Composite Resins on Human Gingival Fibroblasts: An In Vitro Comparative Study
Authors: Ylenia Della Rocca, Enrico Matteo Traini, Oriana Trubiani, Tonino Traini, Antonella Mazzone, Guya Diletta Marconi, Jacopo Pizzicannella, Francesca Diomede
Journal: International Journal of Molecular Sciences
Year: 2024

 

Ahmed Alzahrani | Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Ahmed Alzahrani | Dentistry | Best Researcher Award

King Abdulaziz University | Saudi Arabia

Author Profile

Google Scholar

🏅 Early Academic Pursuits

Dr. Ahmed Alzahrani's journey into pediatric dentistry began with his pursuit of a Bachelor’s degree in Dental Medicine and Surgery at King Abdulaziz University, graduating in June 2013. His academic excellence was evident early on, achieving a remarkable GPA of 4.2. His passion for learning and commitment to pediatric dentistry led him to further his studies, culminating in a Master’s degree in Dental Science in Pediatric Dentistry from the same university, where he excelled with a GPA of 4.7. This strong academic foundation set the stage for his future contributions to the field.

👨‍⚕️ Professional Endeavors

Dr. Alzahrani's professional career is marked by his dedication to pediatric dentistry. He began as a General Dentist at the Ministry of Health in Taif, where he served from February 2013 to March 2016. His commitment to pediatric care led him to specialize in pediatric dentistry, taking on roles as a Pediatric Dentistry Resident and later as a Specialist at the King Abdulaziz University and a specialized dental center in Taif. His expertise and passion for teaching were evident as he supervised undergraduate students in pediatric dentistry clinics at King Abdulaziz University, shaping the next generation of dentists.

🔬 Contributions and Research Focus

Dr. Alzahrani's research is deeply rooted in advancing pediatric dental care. His PhD research at King Abdulaziz University focuses on innovative approaches in pediatric dentistry, including the use of advanced diagnostic tools and materials. His work on the tomographic evaluation of internal adaptation for calcium silicate-based pulp capping materials in primary teeth and his exploration of salivary OMICs for understanding oral and medical diseases have contributed significantly to the field. His passion for research is reflected in his numerous publications, poster presentations, and lectures, where he shares his findings and insights with the broader dental community.

🏆 Accolades and Recognition

Dr. Alzahrani's contributions have not gone unnoticed. He has been recognized with several awards, including 2nd place in the IADR Saudi Division Unilever Hatton Competition at the International Dental Meeting in 2019. His excellence in pediatric dentistry also earned him a Certificate of Excellence from the Director of Health Affairs in Taif in 2016. These accolades underscore his commitment to excellence in both clinical practice and research.

🌟 Impact and Influence

Dr. Alzahrani's impact extends beyond his immediate clinical work. His participation in various conferences, including the organization of the 11th International Conference of KAU, reflects his influence in the academic and professional community. His interest in artificial intelligence, deep learning, and genetic studies indicates his forward-thinking approach, which has the potential to revolutionize pediatric dentistry. Through his teaching, research, and clinical practice, Dr. Alzahrani continues to shape the future of pediatric dentistry, inspiring both his peers and students.

🚀 Legacy and Future Contributions

As Dr. Alzahrani continues his PhD studies and professional endeavors, his future contributions to pediatric dentistry are poised to be groundbreaking. His research interests in AI, deep learning, and microbiome studies suggest that he will be at the forefront of integrating technology with dental care. His dedication to education and research ensures that his legacy will be one of innovation, excellence, and a lasting impact on the field of pediatric dentistry.

 

Publications

  • 📄Tomographic Evaluation of the Internal Adaptation for Recent Calcium Silicate‐Based Pulp Capping Materials in Primary Teeth
    Authors: AA Al Tuwirqi, EA El Ashiry, AY Alzahrani, N Bamashmous, TA Bakhsh
    Journal: BioMed Research International
    Year: 2021
  • 📄 Contemporary Understanding of the Etiology and Management of Molar Incisor Hypomineralization: A Literature Review
    Authors: AY Alzahrani, NMH Alamoudi, OAES El Meligy
    Journal: Dentistry Journal
    Year: 2023
  • 📄 The Influence of Parental Oral Health Literacy on Children's Oral Health: A Scoping Review
    Authors: AY Alzahrani, O El Meligy, D Bahdila, R Aljawi, NO Bamashmous, ...
    Journal: Journal of Clinical Pediatric Dentistry
    Year: 2024
  • 📄 Health and Oral Health Literacy: A Comprehensive Literature Review from Theory to Practice
    Authors: AY Alzahrani, O El Meligy, D Bahdila, R Aljawi, NO Bamashmous, ...
    Journal: International Journal of Paediatric Dentistry
    Year: 2024
  • 📄 The Potential Use of Salivary OMICs in Understanding the Pathogenesis and Diagnosis of Oral and Medical Diseases
    Authors: AY Alzahrani, DA Alblaihed, DY Jamal, ST Ibrahim, GMA Ajabnoor, ...
    Journal: Journal of Microscopy and Ultrastructure
    Year: 2023

 

Kumaresan Sakthiabirami | Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Kumaresan Sakthiabirami | Dentistry | Best Researcher Award 

Chonnam National University | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Kumaresan Sakthiabirami's academic journey in dentistry began with a Bachelor of Dental Surgery (BDS) degree from Rajah Muthiah Dental College and Hospital, Annamalai University, India. Following this, she pursued advanced studies in prosthodontics at Chonnam National University, South Korea, earning a Master's degree in February 2018 and a PhD in August 2020. Her doctoral research focused on implant surface modifications and bone tissue engineering, laying a strong foundation for her future endeavors.

Professional Endeavors

Dr. Sakthiabirami has amassed significant experience in both research and clinical practice. She has worked as a Research Professor at the Biomedical Evaluation and Research Centre, School of Dentistry, Chonnam National University, from May 2022 to July 2023. Prior to this role, she was a Post-Doctoral Research Fellow at the same institution, engaging in cutting-edge research in biomaterials and 3D bioceramic printing. Additionally, she has held positions as a Research Fellow in the Department of Prosthodontics and as an Associate Dental Practitioner in India.

Contributions and Research Focus

Dr. Sakthiabirami's research has been pivotal in the fields of biomaterial development and bone tissue engineering. She has contributed to the development of bone-mimicking 3D porous hybrid zirconia scaffolds and high-strength zirconia for additive manufacturing processes. Her work on implant surface modifications and hydrogels for bone tissue engineering has been widely recognized, and she has published numerous papers on these topics. Her technical expertise includes material synthesis, characterization techniques, and fabrication methods, positioning her as a leader in dental biomaterials research.

Accolades and Recognition

Throughout her career, Dr. Sakthiabirami has received several honors and awards. Notably, she won the Excellence Poster Award from the Korean Academy of Stomatognathic Function and Occlusion in 2019 for her work on argon plasma treatment on titanium surfaces. She has also actively participated in international conferences and seminars, presenting her research at prestigious events such as the International Symposium on Surfaces and Interfaces for Biomaterials and the International Association for Dental Research (IADR).

Impact and Influence

Dr. Sakthiabirami's work has significantly impacted the field of dental research, particularly in implant dentistry and biomaterials. Her innovative approaches to 3D printing and surface modifications have enhanced the development of more effective and durable dental implants and prostheses. Her research has not only advanced academic knowledge but has also contributed to practical applications in clinical dentistry, improving patient outcomes and advancing the field of dental materials.

Legacy and Future Contributions

Looking ahead, Dr. Sakthiabirami's legacy in dental research and practice continues to grow. Her ongoing projects and collaborations are expected to yield further advancements in biomaterials and bone tissue engineering. Her commitment to integrating cutting-edge technology with clinical applications positions her to continue making significant contributions to dental science and education. As she progresses in her career, Dr. Sakthiabirami will undoubtedly remain a key figure in the ongoing evolution of dental research and technology.

 

Notable Publications

Manganese ion batteries: LiV3O8 nanorods as a robust and long-life cathode module 2023 (2)

The Impact of Particle Size and Surface Treatment of Zirconia Suspension for Photocuring Additive Manufacturing 2023 (3)

Effects of UV Absorber on Zirconia Fabricated with Digital Light Processing Additive Manufacturing 2022 (6)

Evaluation of Physical Properties of Zirconia Suspension with Added Silane Coupling Agent for Additive Manufacturing Processes 2022 (12)

Closer to nature: Recreating extracellular matrix microenvironment with 3D printing 2024

 

 

 

Linmang Qin | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Linmang Qin | Medicine and Dentistry | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Lin Mang Qin pursued a Bachelor's degree in Clinical Medicine from Jiujiang University, where he ranked in the top 1% based on comprehensive assessments. He continued his academic journey by completing a Master's degree in Clinical Medicine at South China University of Technology, earning first-class academic scholarships each year during his master's studies.

Professional Endeavors

Currently serving as a Scientific Research Assistant at Guangdong Provincial People’s Hospital since August 2022, Prof. Qin has been deeply involved in theoretical studies, clinical work, and scientific research over the past four years. His responsibilities include conducting basic scientific research at the hospital's public experimental platform and supervising scientific research experiments.

Contributions and Research Focus

Prof. Qin has contributed significantly to the field of clinical medicine, particularly in areas related to autoimmune diseases and gene expression analysis. His research focuses on topics such as fibroblast mesenchymal transition in systemic sclerosis-associated interstitial lung disease (SSc-ILD) and gene expression profiling in polymyositis.

Accolades and Recognition

Prof. Qin's research has garnered international recognition, with publications in prestigious journals such as "iScience" and "Heliyon." Notably, his work has been nominated for the Best Researcher Award, and his methods have been praised by journals for their potential impact on the scientific community.

Impact and Influence

Prof. Qin's research has contributed to advancing our understanding of autoimmune diseases and gene expression regulation, potentially paving the way for novel therapeutic interventions. His involvement in national natural science projects and collaborations with esteemed institutions reflect his impactful contributions to the scientific community.

Legacy and Future Contributions

As the team leader of the public experimental platform at Guangdong Provincial People's Hospital, Prof. Qin continues to mentor and train aspiring researchers while actively engaging in cutting-edge scientific research. His proficiency in various scientific research techniques and dedication to advancing medical knowledge position him as a leader in the field, with a promising future marked by continued innovation and discovery.

Notable Publications

CD4+LAG3+T cells are decreased in SSc-ILD and affect fibroblast mesenchymal transition by TGF-β3 2023

Screening and validation of differentially expressed genes in polymyositis 2024

 

 

Ao Gu | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Ao Gu | Medicine and Dentistry | Best Researcher Award

Shanghai Jiao Tong University School of Medicine | China

Author profile

Scopus

Early Academic Pursuits

Dr. Ao Gu completed his M.B in Clinical Medicine at Hebei University Health Science Center and is pursuing a master's degree at Shanghai Jiao Tong University School of Medicine, focusing on antitumor-active molecules under Prof. Yingbin Liu's mentorship.

Professional Endeavors

With a background in Clinical Medicine, Dr. Gu's professional journey includes extensive research in therapeutic molecules. He actively contributes to the scientific community through his publications and ongoing academic pursuits.

Contributions and Research Focus

Dr. Gu's research primarily centers on exploring the therapeutic capabilities of antitumor-active molecules. His work spans various aspects of medicine and chemistry, ranging from patient-derived models to single-cell omics analysis.

Accolades and Recognition

Dr. Ao Gu has gained recognition for his significant contributions to the field, as evidenced by his publications in reputable scientific journals. His work has been acknowledged for its innovation and potential impact on cancer research.

Impact and Influence

Through his research, Dr. Gu has the potential to influence advancements in cancer treatment and therapeutic molecule development. His contributions add valuable insights to the scientific community's understanding of antitumor agents.

Legacy and Future Contributions

Dr. Ao Gu's legacy lies in his dedication to advancing medical knowledge and developing novel therapeutic approaches. His future contributions are anticipated to further enrich the field of oncology and inspire aspiring researchers in the pursuit of medical excellence.

Notable Publications

Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023

Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)

Solvent-free and Catalyst-free Direct Alkylation of Alkenes 2023 (1)

Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)

 

 

Miguel Angel Perez Rodriguez | Medicine and Dentistry | Editorial Board Member

Posted on by Book of Award

Dr. Miguel Angel Perez Rodriguez | Medicine and Dentistry | Editorial Board Member

Hospital del Niño Poblano | Mexico

Author Profile

Orcid

Early Academic Pursuits

Dr. Miguel Angel Pérez Rodríguez embarked on his academic journey with a degree in physics from the National Autonomous University of Mexico (UNAM). His passion for healthcare led him to pursue a Master's Degree in Health Sciences from the National Polytechnic Institute, with ongoing studies in Health Services Management at the Swiss Institute.

Professional Endeavors

As a seasoned professional, Dr. Pérez Rodríguez holds key roles at the OTAE Clinic (Hospital Puebla) and the Hospital for the Puebla Child. His career includes diverse experiences, such as serving as an advisor at the Children's Hospital of Mexico and contributing to the state cochlear implant program. His private practice at the Cabinet of Audiology and Otoneurology of Puebla, Hospital Ángeles Puebla, reflects his commitment to healthcare.

Contributions and Research Focus

Dr. Pérez Rodríguez's impactful contributions extend to medical scientific publications, international journals, and national books. His research focuses on pediatric otological neurophysiology, central auditory processing disorder, and audiological findings in various patient groups. He holds certifications in Medical Genetics, Pediatric Audiology, and cochlear implant programming.

Accolades and Recognition

Being certified by the Mexican Council of Communication, Audiology, Otoneurology, and Phoniatrics, Dr. Pérez Rodríguez has earned recognition as Vice President of the Mexican Association of Communication, Audiology, Otoneurology, and Phoniatrics for 2023-2025.

Impact and Influence

His influence is evident in his roles as a high-specialty thesis advisor, editor of medical publications, and secretary of the state cochlear implant program. Dr. Pérez Rodríguez's work significantly impacts audiology and healthcare practices.

Legacy and Future Contributions

Dr. Pérez Rodríguez's legacy lies in his extensive research, publications, and contributions to audiology and healthcare in Mexico. As the current Vice President of the Mexican Association of Audiology, his future contributions are poised to further shape and advance the field.

Notable Publications

Vestibular and Balance Disorders in Mexican Children and Adolescents: Review of 8-Year Clinical Records 2021

ASSESSMENT OF CENTRAL AUDITORY PROCESSING DISORDER IN CHILDREN AND ADOLESCENTS TREATED WITH METHYLPHENIDATE DUE TO ATTENTION DEFICIT DISORDER: SYSTEMATIC REVIEW 2020

 

 

 

Aida Sarac Hadzihalilovic | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof Dr. Aida Sarac Hadzihalilovic | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits:

Aida Sarac-Hadzihalilovic commenced her academic journey with her Medical Doctor degree in 1995 from the Medical Faculty, University of Sarajevo. Subsequently, she pursued postgraduate studies in the fundamentals of medical research, culminating in a Master of Science (MSc) degree in 2002. Her dedication led her to earn a Doctoral (PhD) degree in 2006, presenting a thesis on "Quantitative analysis of the hippocampal formation and cognitive dysfunction in posttraumatic stress disorder."

Professional Endeavors:

Starting as an Assistant Lecturer in 1996, she taught anatomy to undergraduates studying medicine, nursing, dentistry, and psychology. Her academic progression led her to positions of increasing responsibility, including Senior Assistant Lecturer (2003-2008), Assistant Professor (2008-2016), and finally, achieving the rank of Full Professor in 2021, all within the Department of Anatomy, Medical Faculty, University of Sarajevo.

Contributions and Research Focus:

Professor Sarac-Hadzihalilovic's vast expertise lies in neuroanatomy and neuroscience, specifically focusing on volumetric brain analysis through structural MRI and the neuropsychological aspects of cognitive dysfunction. She conducted in-depth research on the limbic structures' volumetric analysis, notably the hippocampal formation and amygdala complex, correlating these findings with conditions like post-traumatic stress syndrome and temporal epilepsy. Moreover, her exploration extends to medical anthropology, applying it in skull typisation based on asymmetry, length, width, cephalic index, and cranial capacity, as well as gender skull dimorphism.

Accolades and Recognition:

Her remarkable contributions are evidenced by supervising numerous diploma papers, MSc and PhD students, post-doctoral research fellows, and active involvement in national and international research projects. Professor Sarac-Hadzihalilovic's publication record spans 49 research papers in peer-reviewed international and national journals, 44 contributions to national and international congresses and symposiums, and several authored books, emphasizing the significance of the skull's anatomical-anthropological aspects.

Impact and Influence:

Professor Sarac-Hadzihalilovic's influence transcends academia. She served on scientific committees, advisory boards, editorial boards of peer-reviewed international journals, and held roles as a visiting professor at various universities. Her impact extends to involvement in prestigious EU projects like COST – European Cooperation in Science and Technology, underlining her commitment to advancing research in neuroanatomy and medical anthropology.

Legacy and Future Contributions:

Her legacy lies in shaping the anatomical understanding of future medical professionals. Her continuous commitment to research, publication, and academic engagement promises continued advancements in neuroanatomy, neuroscience, and medical anthropology, enriching medical education and practice for generations to come.

Notable Publications

Radiographic Assessment in the Treatment of Supracondylar Humerus Fractures in Children 2012 (19)

Blood Vessels Distribution in Body and Tail of Pancreas- A Comparative Study of Age Related Variation 2010 (11)

DETERMINATION OF SEX BY DISCRIMINANT FUNCTION ANALYSIS OF LINEAR DIAMETERS IN BOSNIAN HUMAN SKULLS 2017 (4)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (2)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

 

 

Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Sanita Maleskic Kapo began her academic journey at the University of Sarajevo, delving into Pharmacology, Clinical Pharmacology, and Toxicology, culminating in her medical doctorate. Her formative years as a general practitioner at the Primary Health Care Center in Bihać enriched her understanding of patient care and community health.

Professional Endeavors

Transitioning into academia, she embraced teaching roles at the Faculty of Medicine, Sarajevo. Starting as a teaching assistant, her dedication and expertise elevated her to the position of Senior Teaching Assistant. Simultaneously, she embarked on a journey towards a Ph.D. in Pharmacology, further deepening her scholarly pursuits. Additionally, her ongoing residency in Clinical Pharmacology amplifies her practical acumen in the field.

Contributions and Research Focus

Sanita's contributions extend across academia and clinical practice. Her research focus in Pharmacology and Clinical Toxicology underscores her commitment to advancing medical knowledge. This commitment is reflected in her concurrent pursuit of a Ph.D. and residency, showcasing a dedication to scholarly and practical excellence.

Accolades and Recognition

Sanita Maleskic Kapo's journey is enriched by her notable accomplishments and dedication, marking her as a standout professional. While specific accolades may not be explicitly outlined, her multifaceted roles and continued academic progression underscore her recognition within the academic and medical spheres.

Impact and Influence

Her impact resonates through her teaching engagements, shaping future medical professionals. Simultaneously, her research endeavors lay the groundwork for advancements in Pharmacology and Clinical Toxicology, potentially influencing medical practices and patient care.

Legacy and Future Contributions

Sanita's legacy lies in her multifaceted contributions to academia, clinical research, and patient care. Her continued pursuit of a Ph.D. and residency promises a future where her expertise will further illuminate the realms of Pharmacology and Clinical Toxicology, potentially leaving an indelible mark in the field.

Notable Publications

Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study 2017 (27)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (5)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (2)

Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis 2019 (1)